Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Weak
Earnings
Very Strong
Earnings
Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
Nautilus Biotechnolgy, Inc.
Telephone
1.206.333.2001
Address
2701 Eastlake Avenue East, Seattle, WA 98102
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.62 - 4.31
Trade Value (12mth)
US$147,584.00
1 week
-5.18%
1 month
-14.39%
YTD
24.61%
1 year
203.34%
All time high
25.89
EPS 3 yr Growth
0.50%
EBITDA Margin
0.00%
Operating Cashflow
-$51m
Free Cash Flow Return
-24.20%
ROIC
-28.20%
Interest Coverage
0.00
Quick Ratio
13.30
Shares Outstanding (Fully Diluted)
127m
HALO Sector
Other Finance
Next Company Report Date
04-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 29 April 26 | |
| 29 April 26 | |
| 29 April 26 | |
| 28 April 26 | |
| 28 April 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -0.51 | -0.56 | -0.47 | | | | ||
EPS (Fully Diluted) | $ | | | | | -0.51 | -0.56 | -0.47 | | | | ||
Growth | % | | | | | -9.6 | -10.7 | 17.2 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
